Effect of monocerin, a fungal secondary metabolite, on endothelial cells


Publication type
Article
Language
English
Access rights
Open access
Terms of use
CC BY
Appears in Collections:
Metrics
Abstract
This study reports the isolation and identification of the endophytic fungus Exserohilum rostratum through molecular and morphological analysis using optical and transmission electron microscopy (TEM), as well as the procurement of its secondary metabolite monocerin, an isocoumarin derivative. Considering the previously observed biological activities of monocerin, this study was performed on human umbilical vein endothelial cells (HUVECs) that are widely used as an in vitro model for several different purposes. Important parameters, such as cell viability, senescence-associated β-galactosidase, cellular proliferation by using 5(6)-carboxyfluorescein diacetate N-succinimidyl ester (CFSE), apoptosis analysis with annexin, cellular morphology through scanning electron microscopy (SEM), and laser confocal analysis were evaluated after exposing the cells to monocerin. After 24 h of exposure to monocerin at 1.25 mM, there was more than 80% of cell viability and a low percentage of cells in the early and late apoptosis and necrosis. Monocerin increased cell proliferation and did not induce cell senescence. Morphological analysis showed cellular integrity. The study demonstrates aspects of the mechanism of action of monocerin on endothelial cell proliferation, suggesting the possibility of its pharmaceutical application, such as in regenerative medicine.
Reference
Gomes TC, Conrado R, Oliveira RC, Selari PJRG, Melo IS, Araújo WL, et al. Effect of monocerin, a fungal secondary metabolite, on endothelial cells. Toxins. 2023 May; 15(5):344. doi:10.3390/toxins15050344.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/4916
Journal title
Issue Date
2023


Files in This Item:

Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.